UBV
United Bank (Virginia) Portfolio holdings
AUM $835M
1-Year Return
14.61%
This Quarter Return
+6.79%
1 Year Return
+14.61%
3 Year Return
+55.61%
5 Year Return
+104.58%
10 Year Return
+207.91%
AUM
$813M
AUM Growth
+$30.7M
(+3.9%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
45.68%
Holding
166
New
5
Increased
24
Reduced
59
Closed
11
Top Buys
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$9.56M |
| 2 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$4.12M |
| 3 |
Cummins
CMI
|
+$2.39M |
| 4 |
Exxon Mobil
XOM
|
+$2.38M |
| 5 |
Pfizer
PFE
|
+$1.86M |
Top Sells
| 1 |
Albemarle
ALB
|
+$4.3M |
| 2 |
iShares Short Treasury Bond ETF
SHV
|
+$3.9M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
+$2.54M |
| 4 |
Microsoft
MSFT
|
+$2.42M |
| 5 |
United Rentals
URI
|
+$2.33M |
Sector Composition
| 1 | Industrials | 23.92% |
| 2 | Technology | 16.59% |
| 3 | Healthcare | 9.99% |
| 4 | Financials | 8.28% |
| 5 | Consumer Staples | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Lockheed Martin
LMT
$110B
| $268K | 0.03% |
582
| – | – |
|
127
Dow Inc
DOW
$17.4B
| $268K | 0.03% |
5,029
-275
| -5% | -$14.6K |
|
128
Zimmer Biomet
ZBH
$19.8B
| $268K | 0.03% |
1,838
-678
| -27% | -$98.7K |
|
129
Liberty Media Series C
FWONK
$25.5B
| $267K | 0.03% |
3,672
| – | – |
|
130
Aflac
AFL
$58.4B
| $267K | 0.03% |
3,826
-76
| -2% | -$5.31K |
|
131
UnitedHealth
UNH
$309B
| $266K | 0.03% |
553
| – | – |
|
132
American Express
AXP
$234B
| $262K | 0.03% |
1,505
| – | – |
|
133
Garmin
GRMN
$45.1B
| $261K | 0.03% |
2,500
| – | – |
|
134
FNB Corp
FNB
$5.84B
| $251K | 0.03% |
21,900
| – | – |
|
135
Xylem
XYL
$34.3B
| $248K | 0.03% |
2,200
| – | – |
|
136
EPAM Systems
EPAM
$8.55B
| $242K | 0.03% |
1,075
| – | – |
|
137
Bank of America
BAC
$381B
| $240K | 0.03% |
8,376
| – | – |
|
138
Booking.com
BKNG
$180B
| $230K | 0.03% |
+85
| New | +$230K |
|
139
Norfolk Southern
NSC
$62.4B
| $225K | 0.03% |
994
| – | – |
|
140
Costco
COST
$427B
| $216K | 0.03% |
401
-10
| -2% | -$5.38K |
|
|
141
Albemarle
ALB
$9.43B
| $216K | 0.03% |
967
-19,284
| -95% | -$4.3M |
|
142
TJX Companies
TJX
$156B
| $208K | 0.03% |
+2,450
| New | +$208K |
|
143
Peoples Bancorp
PEBO
$1.08B
| $207K | 0.03% |
7,790
-459
| -6% | -$12.2K |
|
144
Vanguard Dividend Appreciation ETF
VIG
$97.9B
| $207K | 0.03% |
+1,272
| New | +$207K |
|
145
iShares Russell 1000 ETF
IWB
$44.4B
| $201K | 0.02% |
+825
| New | +$201K |
|
146
CVS Health
CVS
$93.9B
| $200K | 0.02% |
2,895
| – | – |
|
147
AgEagle Aerial Systems
UAVS
$61.3M
| $158K | 0.02% |
686
| – | – |
|
148
Trevi Therapeutics
TRVI
$972M
| $68K | 0.01% |
28,450
| – | – |
|
|
IRD
149
Opus Genetics, Inc. Common Stock
IRD
$85.7M
| $51.2K | 0.01% |
11,800
| – | – |
|
150
Lineage Cell Therapeutics
LCTX
$317M
| $36.1K | ﹤0.01% |
+25,600
| New | +$36.1K |
|